Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

SBI Life Insurance - Q3FY21 First Cut - ICICI Direct

Posted On: 2021-01-22 22:49:55 (Time Zone: Arizona, USA)

(CMP - Rs. 866, MCap- Rs. 86630 crore)

SBI Life Insurance reported a mixed performance wherein premium accretion came healthy. However, higher actuarial liability offset investment income, led to lower than expected surplus and earnings.

Q3FY21 Earnings Summary

- Premium growth remained healthy at 18% YoY to Rs. 13766 crore, led by higher traction in renewal (up 24% YoY) and single premium (up 16.5% YoY). Growth in renewal premium continued to remain healthy at ~24% YoY to Rs. 8436 crore, with renewal rate at 85% comparable with Q3FY20. New Business Premium (NBP) witnessed moderation in growth at 9.5% YoY to Rs. 5439 crore, led by flattish group business. In terms of NBP breakup, traction in individual business witnessed gradual pick up at Rs. 3700 crore as against Rs. 3430 crore in Q3FY20, primarily led by ~63% YoY rise in non-par business. Protection business (individual + group) continued to report strong growth at Rs. 710 crore in Q3FY21 vs Rs. 510 crore in Q3FY20. Proportion of total protection NBP to total NBP stood at ~13% in Q3FY21. Group savings products business remained flat YoY at Rs. 1030 crore.

- AUM growth accelerated 28% YoY to Rs. 209500 crore. Shareholders and policyholders (excluding linked liabilities) assets witnessed healthy growth at ~24% and ~21% YoY, respectively. Assets held in lieu of linked products jumped ~33% YoY to Rs. 109448 crore. Recovery in equity market and decline in yields led to strong investment income at Rs. 12777 crore (up 213% YoY) in Q3FY21, supporting total revenue trajectory.

- Commission expenses increased 13.6% YoY to Rs. 517 crore, while commission ratio declined ~80 bps to 4.7%. Consequently, management expense ratio improved by ~100 bps to 8.4% in Q3FY20 (absolute opex at Rs. 1162 crore)

- Steady premium growth coupled with healthy investment income provided a boost to traction in top-line. However, higher actuarial liability led to lower policyholder surplus at Rs. 296 crore (below our estimate). Lower surplus led to muted allocation to shareholders at Rs. 66 crore vs. Rs. 113 crore QoQ and Rs. 217 crore YoY. Subsequently, PAT came lower than estimate at Rs. 233 crore.

- Solvency ratio was healthy at 2.34x as against 2.3x in Q3FY20

We would be shortly coming out with a detailed report.

Shares of SBI Life Insurance Company Ltd was last trading in BSE at Rs.861.6 as compared to the previous close of Rs. 879.25. The total number of shares traded during the day was 174279 in over 10248 trades.

The stock hit an intraday high of Rs. 885.45 and intraday low of 838.2. The net turnover during the day was Rs. 150434947.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Wipro - Beware of integration / impairment risks! - ICICI Securities

Easy Trip Planners Ltd - IPO Review - ICICI Direct

ICICI Direct - Derivatives Weekly View (March 5): Level of 14700 remains crucial for upsides to continue...

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020